## **Core Concept**
Long-term complications of renal transplantation refer to issues that arise more than 10 years after the transplant surgery. These complications can affect the function and longevity of the transplanted kidney and the overall health of the recipient. They are critical to understand for the management and follow-up of renal transplant patients.

## **Why the Correct Answer is Right**
The correct answer, **C. Chronic allograft nephropathy**, is a long-term complication of renal transplantation. Chronic allograft nephropathy, also known as chronic transplant nephropathy, is a major cause of late graft failure. It is characterized by a gradual decline in kidney function, often due to a combination of factors including chronic rejection, drug toxicity (especially from calcineurin inhibitors), and recurrent kidney disease. This condition can lead to fibrosis and scarring within the graft, ultimately compromising its function.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While acute rejection is a significant concern in the early stages post-transplant, it is not typically considered a long-term complication (>10 years) but rather an early complication.
- **Option B:** Although certain infections can occur long-term post-transplant due to immunosuppression, such as CMV or EBV-related issues, they are not specifically categorized under a single term like "chronic allograft nephropathy" for long-term renal complications.
- **Option D:** Post-transplant lymphoproliferative disorder (PTLD) is indeed a complication of immunosuppression but is more of a specific type of complication rather than a broad category like chronic allograft nephropathy.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **chronic allograft nephropathy** is a leading cause of late graft failure in renal transplant recipients. Monitoring for signs of chronic nephropathy, such as gradual increases in serum creatinine and proteinuria, is crucial for long-term management. Adjustments in immunosuppressive therapy may be necessary to balance the risk of rejection with the risk of nephrotoxicity.

## **Correct Answer: C. Chronic allograft nephropathy**